Gland Pharma Ltd. Financials

NSE BSE

15:57 Jul 18

Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2000.30

-7.40 (-0.37%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2000.30

-7.40 (-0.37%)
15:57 Jul 18

Quality

57/100
High Financial Strength

Valuation

33/100
Mid Valuation

Technical

63/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	3462.88	4400.71	3624.6	5664.72	5616.5
Operating Expenses +	2160.65	2890.55	2599.83	4331.65	4347.58
Raw Material	1765.36	2072.52	1732.34	2275.2	1986.97
Increase Decrease in Cost	-273.49	36.69	-46.92	127.88	103.41
Other Manufacturing Expense	74.58	95.05	124.84	0	0
Employee Cost	311.36	338.57	403.26	1256.89	1401.56
Miscellaneous Expenses	315.24	399.04	417.49	717.82	884.62
Operating Profit	1302.23	1510.16	1024.77	1333.07	1268.92
Other Income	134.78	223.94	240.46	170.24	213.61
Depreciation	98.78	110.3	146.74	344.57	377.87
Interest	3.41	5.24	7.45	26.2	42
Profit before tax and exceptio..	1334.81	1618.55	1111.04	1132.54	1062.66
Exceptional Items	0	0	-56.46	0	0
PBT	1334.81	1618.55	1054.58	1132.54	1062.66
Provision for Taxation	337.85	406.89	273.54	360.08	364.13
Net Profit	996.96	1211.66	781.04	772.46	698.53
NET Profit after MI	996.96	1211.66	781.04	772.46	698.53
EPS	62.99	73.81	47.43	46.9	42.4
Operating Profit Margin (%)	37.61	34.32	28.27	23.53	22.59
Net Profit Margin (%)	28.79	27.53	21.55	13.64	12.44

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	51.80	51.80	51.80	51.80	51.80
FII	7.40	6.90	5.00	4.50	6.90
MF	30.70	31.20	32.40	32.80	30.50
Others	2.10	2.10	2.40	2.50	2.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: